Eriksen, R.* ; White, M.C.* ; Dawed, A.Y.* ; Garcia Perez, I.* ; Posma, J.M.* ; Haid, M. ; Sharma, S. ; Prehn, C. ; Thomas, L.E.* ; Koivula, R.W.* ; Bizzotto, R.* ; Mari, A.* ; Giordano, G.N.* ; Pavo, I.* ; Schwenk, J.M.* ; De Masi, F.* ; Tsirigos, K.D.* ; Brunak, S.* ; Viñuela, A.* ; Mahajan, A.* ; McDonald, T.J.* ; Kokkola, T.* ; Rutters, F.* ; Beulens, J.* ; Muilwijk, M.* ; Blom, M.T.* ; Elders, P.* ; Hansen, T.H.* ; Fernandez-Tajes, J.* ; Jones, A.* ; Jennison, C.* ; Walker, M.* ; McCarthy, M.I.* ; Pedersen, O.* ; Ruetten, H.* ; Forgie, I.* ; Holst, J.J.* ; Thomsen, H.S.* ; Ridderstråle, M.* ; Bell, J.D.* ; Adamski, J. ; Franks, P.W.* ; Hansen, T.* ; Holmes, E.* ; Frost, G.* ; Pearson, E.R.*
The association of cardiometabolic, diet and lifestyle parameters with plasma glucagon-like peptide-1: An IMI DIRECT study.
J. Clin. Endocrinol. Metab. 109, e1697-e1707 (2024)
CONTEXT: The role of glucagon-like peptide-1(GLP-1) in Type 2 diabetes (T2D) and obesity is not fully understood. OBJECTIVE: We investigate the association of cardiometabolic, diet and lifestyle parameters on fasting and postprandial GLP-1 in people at risk of, or living with, T2D. METHOD: We analysed cross-sectional data from the two Innovative Medicines Initiative (IMI) Diabetes Research on Patient Stratification (DIRECT) cohorts, cohort 1(n=2127) individuals at risk of diabetes; cohort 2 (n=789) individuals with new-onset of T2D. RESULTS: Our multiple regression analysis reveals that fasting total GLP-1 is associated with an insulin resistant phenotype and observe a strong independent relationship with male sex, increased adiposity and liver fat particularly in the prediabetes population. In contrast, we showed that incremental GLP-1 decreases with worsening glycaemia, higher adiposity, liver fat, male sex and reduced insulin sensitivity in the prediabetes cohort. Higher fasting total GLP-1 was associated with a low intake of wholegrain, fruit and vegetables inpeople with prediabetes, and with a high intake of red meat and alcohol in people with diabetes. CONCLUSION: These studies provide novel insights into the association between fasting and incremental GLP-1, metabolic traits of diabetes and obesity, and dietary intake and raise intriguing questions regarding the relevance of fasting GLP-1 in the pathophysiology T2D.
Altmetric
Additional Metrics?
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Corresponding Author
Keywords
GLP-1; type 2 diabetes; prediabetes; liver fat; obesity; insulin resistance; incretin; nutrition; diet; cardiometabolic markers; Mixed Meal; Glp-1; Secretion; Discovery; Cells; Risk
Keywords plus
ISSN (print) / ISBN
0021-972X
e-ISSN
1945-7197
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 109,
Issue: 9,
Pages: e1697-e1707
Article Number: ,
Supplement: ,
Series
Publisher
Endocrine Society
Publishing Place
Bethesda, Md.
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Molekulare Endokrinologie und Metabolismus (MEM)
Institute of Epidemiology (EPI)
Grants
Wellcome
Rutherford Fund Fellowship at Health Data Research (HDR) UK
NIHR Fellowship
Imperial College National Institute for Health Research (NIHR) BRC
European Union
Novo Nordisk Foundation
Swedish Research Council, Linnaeus
Swedish Foundation for Strategic Research
Lund University Diabetes Centre
Swedish Research Council
STAR Award Novo Nordisk
NIHR (Niddk)
Innovative Medicines Initiative Joint Undertaking